blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

Podcast recap: Jocelynn Pearl on systems biology, decentralized science, and innovation in cancer cell therapy

In last week’s episode of The Genetics Podcast, Patrick spoke with Jocelynn Pearl, Director of Cancer Cell Therapy at the TAM Center. With a career spanning gen...
Continue reading

Building compliance into precision medicine recruitment

In precision medicine trials, recruitment and compliance are interdependent workstreams. Every step that brings a patient closer to enrollment, from digital out...
Continue reading

Podcast recap: Dr. Eric Adler on the future of cardiovascular medicine

In last week’s episode of The Genetics Podcast, Patrick Short spoke with Dr. Eric Adler, Professor of Medicine at UC San Diego and Chief Medical Officer at Lexe...
Continue reading

How biotechs can optimize data management and clinical trials to scale precision medicine with limited resources

Effective data management and innovative clinical trial designs are pivotal in advancing precision medicine, particularly for biotech companies operating with b...
Continue reading

Scaling precision medicine in biotech: Tools & methods

Precision medicine is built on the premise that treatment and prevention strategies should account for individual variability in genes, environment, and lifesty...
Continue reading

Podcast recap: Dr. Erik Ingelsson on RNA editing, target discovery, and the future of precision medicine

Recently on The Genetics Podcast, Patrick sat down with Dr. Erik Ingelsson, Chief Scientific Officer at Wave Life Sciences, to explore some of the most exciting...
Continue reading

Precision medicine landscape for cardiometabolic conditions

Precision medicine approaches to cardiometabolic conditions are still in their infancy but stand poised to transform treatment approaches and are increasingly r...
Continue reading

The state of precision medicine in cardiovascular and metabolic disease [report]

Cardiovascular disease remains a leading global health concern, claiming millions of lives each year and disproportionately affecting communities worldwide. Fac...
Continue reading

Gene therapy regulation: FDA-accelerated approval & orphan drug designation

As of March 2023, 3,900 gene therapy trials were noted as ongoing, completed, or approved across 46 different countries. An analysis of the second quarter of 20...
Continue reading

Cell and gene therapy: How innovation is changing rare disease treatment

Cell and gene therapies (CGTs) are reshaping what it means to treat disease. Instead of managing symptoms over a lifetime, these approaches aim to address disea...
Continue reading